Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.

The present invention is related to a method for obtaining dental pulp and root cement in the forensic dentistry field, wherein the method comprises the steps of: (a) obtaining a tooth; (b) taking a digital radiography to the tooth; (c) external rehydrating of the tooth; (d) perforating the rehydrated tooth; (e) internal rehydrating of dentin pulp complex (f) obtaining rehydrated root cement; (g) obtaining rehydrated dental pulp content with a low speed rotation tool; and (h) storing, preservation, processing and/or analyses of the rehydrated dental pulp content and rehydrated root cement, and the use of this method and kits thereof for forensic identification, estimation of post mortem interval (early and late) and determination of possible causes of death.

The present invention is related to a method for obtaining dental pulp and root cement in the forensic dentistry field, wherein the method comprises the steps of: (a) obtaining a tooth; (b) taking a digital radiography to the tooth; (c) external rehydrating of the tooth; (d) perforating the rehydrated tooth; (e) internal rehydrating of dentin pulp complex (f) obtaining rehydrated root cement; (g) obtaining rehydrated dental pulp content with a low speed rotation tool; and (h) storing, preservation, processing and/or analyses of the rehydrated dental pulp content and rehydrated root cement, and the use of this method and kits thereof for forensic identification, estimation of post mortem interval (early and late) and determination of possible causes of death.

A portable machine for arterial embalming includes a tank assembly and a control assembly. The control assembly includes a fluid pressure gauge fluidly connected to a fluid output of a syringe vessel assembly of the tank assembly; a fluid injection tube fluidly connected to the fluid pressure gauge and configured for injection into the human cadaver body; a motor connected to a push rod that is connected to the syringe vessel assembly, wherein the motor drives the push rod to actuate the syringe vessel assembly to produce a flow of fluid from the tank assembly to the fluid pressure gauge; and a motor speed controller connected for varying a speed of the motor and for varying a maximum fluid pressure measured by the fluid pressure gauge, and, in turn, pressure filtration of fluid entering the human cadaver body.

In one embodiment, a freezer system has one or more shelves, each shelf has shelf electronics and can receive one or more racks, each rack has rack electronics and one or more cells for receiving one or more boxes of samples, each box has one or more RFID tags. Freezer electronics communicate with the outside world and with each set of shelf electronics. Each set of rack electronics communicates wirelessly with the corresponding set of shelf electronics and with the corresponding box RFID tags. Power for the rack electronics is derived from wireless signals from the shelf electronics. The freezer system can detect the presence of racks on shelves and boxes on racks to track the location and the orientation of each received box.

In one embodiment, a freezer system has one or more shelves, each shelf has shelf electronics and can receive one or more racks, each rack has rack electronics and one or more cells for receiving one or more boxes of samples, each box has one or more RFID tags. Freezer electronics communicate with the outside world and with each set of shelf electronics. Each set of rack electronics communicates wirelessly with the corresponding set of shelf electronics and with the corresponding box RFID tags. Power for the rack electronics is derived from wireless signals from the shelf electronics. The freezer system can detect the presence of racks on shelves and boxes on racks to track the location and the orientation of each received box.

A system for growing cells comprising a bioreactor chamber for growing the cells, a delivery system delivering a perfusion solution to the bioreactor chamber for perfusion of the perfusion solution through the cells, a dialysis system having a dialyzer, a dialysate for performing a dialysis and a filter for reducing ammonia content in said dialysate, and a controller that circulates the perfusion solution through the dialyzer and the dialysate through the filter.

Methods are provided for quantifying specific proteins directly in biological samples that have been fixed in formalin by SRM/MRM assay. Such biological samples are chemically preserved and fixed wherein said biological sample is selected from tissues and cells treated with formaldehyde containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks. A protein digest is prepared from the biological sample using, for example, the Liquid Tissue reagents and protocol and a designated protein is quantitated in the digest sample by the method of SRM/MRM mass spectrometry by quantitating in the protein sample at least one or more of the described peptides. The proteins that can be detected and/or quantitated are CD3D, B7H3, B7-2, STAT1, GBP1, GPNMB, CD27, CD3E, and CD8.

A collected living tissue cryopreserving tool is composed of a tissue piece holder and a resin-made accommodating bag. The tissue piece holder is composed of a plate-shaped body part including a thermally conductive plate-shaped lower member and a plate-shaped upper member and a covering sheet held by the plate-shaped body part. The tissue piece holder has a tissue piece placing part formed of a cut-out part provided on the plate-shaped upper member and a part, of an upper surface of the thermally conductive plate-shaped lower member, which is disposed at the cut-out part. The covering sheet is capable of covering the tissue piece placing part.

This disclosure relates to a composition that, in some embodiments, includes cryopreserved platelets; and a cryoprotectant, wherein the composition comprises less than 6% (v/v) of dimethyl sulfoxide (DMSO). In some embodiments, the composition is substantially free of dimethyl sulfoxide (DMSO).